

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.27840316 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.27840316 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.27840316 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.27840316 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.27840316 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.27840316 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.32793063 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.18954117 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.12304261 |
| 10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.65990793 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.58304176 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.54023134 |
| 13 | response to peptidoglycan (GO:0032494) | 4.50460380 |
| 14 | glycosphingolipid catabolic process (GO:0046479) | 4.49496907 |
| 15 | respiratory burst (GO:0045730) | 4.47467944 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.36867408 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.32065563 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.26890273 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.13111422 |
| 20 | response to host immune response (GO:0052572) | 4.13111422 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.07845040 |
| 22 | pinocytosis (GO:0006907) | 4.07553249 |
| 23 | glycolipid catabolic process (GO:0019377) | 4.03456515 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.93833191 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.93833191 |
| 26 | positive regulation of antigen processing and presentation (GO:0002579) | 3.92704088 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.87955863 |
| 28 | oligosaccharide catabolic process (GO:0009313) | 3.82905184 |
| 29 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.78599171 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.77632632 |
| 31 | response to host (GO:0075136) | 3.77632632 |
| 32 | response to host defenses (GO:0052200) | 3.77632632 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75156513 |
| 34 | myeloid cell activation involved in immune response (GO:0002275) | 3.72680342 |
| 35 | ceramide catabolic process (GO:0046514) | 3.68651766 |
| 36 | microglial cell activation (GO:0001774) | 3.62049665 |
| 37 | amino sugar catabolic process (GO:0046348) | 3.60999226 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.59769779 |
| 39 | neutrophil mediated immunity (GO:0002446) | 3.58065402 |
| 40 | cellular extravasation (GO:0045123) | 3.56441215 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.38126761 |
| 42 | B cell mediated immunity (GO:0019724) | 3.35201206 |
| 43 | neutrophil activation (GO:0042119) | 3.33830202 |
| 44 | macrophage activation (GO:0042116) | 3.28676799 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.26233584 |
| 46 | granulocyte activation (GO:0036230) | 3.23841673 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.23099053 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21576467 |
| 49 | negative regulation of phagocytosis (GO:0050765) | 3.20957023 |
| 50 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.17456410 |
| 51 | response to thyroid hormone (GO:0097066) | 3.16788902 |
| 52 | positive regulation of interferon-beta production (GO:0032728) | 3.07205572 |
| 53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07076670 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.05065305 |
| 55 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.02959244 |
| 56 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.02959244 |
| 57 | actin nucleation (GO:0045010) | 3.02226258 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 2.99017368 |
| 59 | mannose metabolic process (GO:0006013) | 2.93612342 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 2.93065744 |
| 61 | leukocyte mediated cytotoxicity (GO:0001909) | 2.92571110 |
| 62 | regulation of B cell differentiation (GO:0045577) | 2.92554448 |
| 63 | sphingolipid catabolic process (GO:0030149) | 2.91738297 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87550153 |
| 65 | superoxide anion generation (GO:0042554) | 2.86514420 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 2.83966610 |
| 67 | response to fungus (GO:0009620) | 2.81339443 |
| 68 | myeloid leukocyte activation (GO:0002274) | 2.80722664 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80647782 |
| 70 | N-acetylneuraminate metabolic process (GO:0006054) | 2.80380300 |
| 71 | negative regulation of granulocyte differentiation (GO:0030853) | 2.79340525 |
| 72 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.78916066 |
| 73 | natural killer cell mediated immunity (GO:0002228) | 2.78629885 |
| 74 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.78629885 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 2.78621149 |
| 76 | membrane lipid catabolic process (GO:0046466) | 2.78608898 |
| 77 | reactive oxygen species biosynthetic process (GO:1903409) | 2.78001448 |
| 78 | B cell receptor signaling pathway (GO:0050853) | 2.77988546 |
| 79 | leukotriene metabolic process (GO:0006691) | 2.77879045 |
| 80 | mast cell activation (GO:0045576) | 2.77542853 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 2.77003436 |
| 82 | regulation of mononuclear cell migration (GO:0071675) | 2.76966409 |
| 83 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.76708972 |
| 84 | autophagic vacuole fusion (GO:0000046) | 2.75237235 |
| 85 | myeloid dendritic cell activation (GO:0001773) | 2.72292270 |
| 86 | I-kappaB phosphorylation (GO:0007252) | 2.70734529 |
| 87 | detection of bacterium (GO:0016045) | 2.70425676 |
| 88 | regulation of superoxide anion generation (GO:0032928) | 2.68420149 |
| 89 | negative regulation of interleukin-17 production (GO:0032700) | 2.68354726 |
| 90 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67623221 |
| 91 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.67251391 |
| 92 | response to interferon-beta (GO:0035456) | 2.65256998 |
| 93 | myeloid leukocyte mediated immunity (GO:0002444) | 2.64191778 |
| 94 | leukocyte degranulation (GO:0043299) | 2.63866402 |
| 95 | response to interferon-alpha (GO:0035455) | 2.63330526 |
| 96 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62422405 |
| 97 | negative regulation of interleukin-6 production (GO:0032715) | 2.60475732 |
| 98 | detection of other organism (GO:0098543) | 2.60350929 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59708712 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59658236 |
| 101 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.57529874 |
| 102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57132812 |
| 103 | apoptotic cell clearance (GO:0043277) | 2.57108856 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 2.56409520 |
| 105 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.55605450 |
| 106 | regulation of leukocyte degranulation (GO:0043300) | 2.55532920 |
| 107 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.53537020 |
| 108 | positive regulation of chemokine secretion (GO:0090197) | 2.52659090 |
| 109 | leukocyte aggregation (GO:0070486) | 2.52645146 |
| 110 | dendritic cell differentiation (GO:0097028) | 2.50442467 |
| 111 | neutrophil chemotaxis (GO:0030593) | 2.49695415 |
| 112 | mature B cell differentiation involved in immune response (GO:0002313) | 2.49472699 |
| 113 | defense response to protozoan (GO:0042832) | 2.49129152 |
| 114 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48370502 |
| 115 | cellular response to interferon-beta (GO:0035458) | 2.48369488 |
| 116 | keratan sulfate catabolic process (GO:0042340) | 2.47473653 |
| 117 | complement activation, alternative pathway (GO:0006957) | 2.47172035 |
| 118 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.46795310 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.45908165 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.45908165 |
| 121 | negative regulation of innate immune response (GO:0045824) | 2.45653690 |
| 122 | regulation of cholesterol storage (GO:0010885) | 2.45424596 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.45328519 |
| 124 | regulation of B cell apoptotic process (GO:0002902) | 2.44837241 |
| 125 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.39797291 |
| 126 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.37313602 |
| 127 | negative regulation of B cell apoptotic process (GO:0002903) | 2.36786892 |
| 128 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.35491516 |
| 129 | L-phenylalanine metabolic process (GO:0006558) | 2.35330499 |
| 130 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.35330499 |
| 131 | amyloid precursor protein catabolic process (GO:0042987) | 2.34093827 |
| 132 | lysosome organization (GO:0007040) | 2.33654501 |
| 133 | lytic vacuole organization (GO:0080171) | 2.33654501 |
| 134 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.33103873 |
| 135 | pentose metabolic process (GO:0019321) | 2.32983097 |
| 136 | peptide catabolic process (GO:0043171) | 2.32551343 |
| 137 | pyrimidine nucleoside salvage (GO:0043097) | 2.31737730 |
| 138 | pyrimidine-containing compound salvage (GO:0008655) | 2.31737730 |
| 139 | lipopolysaccharide metabolic process (GO:0008653) | 2.31246613 |
| 140 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.30214260 |
| 141 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.29950235 |
| 142 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.29126409 |
| 143 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.25215238 |
| 144 | plasma lipoprotein particle clearance (GO:0034381) | 2.24905079 |
| 145 | negative regulation of cell killing (GO:0031342) | 2.22910707 |
| 146 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.22910707 |
| 147 | regulation of cholesterol esterification (GO:0010872) | 2.22314992 |
| 148 | regulation of monocyte differentiation (GO:0045655) | 2.22239784 |
| 149 | macrophage differentiation (GO:0030225) | 2.21706853 |
| 150 | detection of external biotic stimulus (GO:0098581) | 2.20584877 |
| 151 | positive regulation of mast cell degranulation (GO:0043306) | 2.19172262 |
| 152 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.19172262 |
| 153 | UV protection (GO:0009650) | 2.18757695 |
| 154 | response to protozoan (GO:0001562) | 2.18325340 |
| 155 | phospholipid efflux (GO:0033700) | 2.17954869 |
| 156 | purine nucleotide salvage (GO:0032261) | 2.16584534 |
| 157 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.15019945 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.14261019 |
| 159 | L-phenylalanine catabolic process (GO:0006559) | 2.14261019 |
| 160 | nucleotide salvage (GO:0043173) | 2.14072706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.09875286 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75681918 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.31792272 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22493650 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.60334934 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54647640 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48970853 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.25405830 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.11290837 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.10850986 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89588303 |
| 12 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.72202471 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.68201372 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67793924 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.47550402 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.46480621 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35819093 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32777712 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31349804 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25184505 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22824296 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.17851452 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03573686 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03490028 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02635113 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00695397 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98237718 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95247803 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89835975 |
| 30 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.87021639 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.86540480 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84027939 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82068887 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.79665401 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.72670631 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72159216 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71225575 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.68755573 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65724264 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64027226 |
| 41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62227121 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61923022 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60287638 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60129351 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59398190 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57934070 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54447630 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.53054916 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52454357 |
| 50 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52262195 |
| 51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.50941037 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.45889043 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45841744 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44485893 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41185370 |
| 56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38851418 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37821620 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37431793 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37184556 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.37154291 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36278315 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34268319 |
| 63 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33243737 |
| 64 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.32415462 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32094929 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31816206 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31022611 |
| 68 | P68_20966046_ChIP-Seq_HELA_Human | 1.30221815 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30080443 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25971173 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25696169 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23154900 |
| 73 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22103746 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20960799 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19225259 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18018587 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17716903 |
| 78 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17311205 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17209738 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16497558 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14472731 |
| 82 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13929060 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13580069 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13446436 |
| 85 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.13239429 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13124400 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12621164 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10132513 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08676122 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08358332 |
| 91 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06604272 |
| 92 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05752491 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05554034 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04798158 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04361468 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04236972 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04054585 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03573478 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03539964 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03389936 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02275619 |
| 102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01134898 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00899497 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00603321 |
| 105 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00569909 |
| 106 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00137871 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99913350 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98984244 |
| 109 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98271235 |
| 110 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98074855 |
| 111 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94862865 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.94593935 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94045769 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92342319 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92040328 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91192458 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88948412 |
| 118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88480532 |
| 119 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88164570 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87157905 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85265610 |
| 122 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.81534475 |
| 123 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.80395828 |
| 124 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.76759355 |
| 125 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.76698102 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76152261 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75489255 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75441882 |
| 129 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.74915062 |
| 130 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.73771093 |
| 131 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.73707395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005058_abnormal_lysosome_morphology | 3.89173230 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.80217758 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.59536165 |
| 4 | MP0003436_decreased_susceptibility_to | 3.48968800 |
| 5 | MP0003303_peritoneal_inflammation | 3.17724272 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.12938625 |
| 7 | MP0002419_abnormal_innate_immunity | 2.95389648 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.89719004 |
| 9 | MP0006082_CNS_inflammation | 2.65606527 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.56804233 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.54979624 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.54686592 |
| 13 | MP0009785_altered_susceptibility_to | 2.49499650 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.43421566 |
| 15 | MP0005025_abnormal_response_to | 2.42703605 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.38321924 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.27655158 |
| 18 | MP0009840_abnormal_foam_cell | 2.21100261 |
| 19 | MP0005387_immune_system_phenotype | 2.20946051 |
| 20 | MP0001790_abnormal_immune_system | 2.20946051 |
| 21 | MP0000685_abnormal_immune_system | 2.17776455 |
| 22 | MP0001800_abnormal_humoral_immune | 2.14766111 |
| 23 | MP0005365_abnormal_bile_salt | 2.06740629 |
| 24 | MP0002723_abnormal_immune_serum | 2.05735727 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.02213957 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.02118906 |
| 27 | MP0001819_abnormal_immune_cell | 2.00753366 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.00258297 |
| 29 | MP0003724_increased_susceptibility_to | 1.91672750 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.91417964 |
| 31 | MP0005671_abnormal_response_to | 1.90158151 |
| 32 | MP0005451_abnormal_body_composition | 1.87039192 |
| 33 | MP0002405_respiratory_system_inflammati | 1.84673325 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.80153257 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.69576459 |
| 36 | MP0005360_urolithiasis | 1.69411197 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.60825849 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.59540030 |
| 39 | MP0010307_abnormal_tumor_latency | 1.59412589 |
| 40 | MP0000716_abnormal_immune_system | 1.56036199 |
| 41 | MP0002398_abnormal_bone_marrow | 1.54883479 |
| 42 | MP0000343_altered_response_to | 1.54214127 |
| 43 | MP0008469_abnormal_protein_level | 1.53237478 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.52099628 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.51949574 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.51944733 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.48847611 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48499513 |
| 49 | MP0003448_altered_tumor_morphology | 1.47059174 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.46556635 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.44890038 |
| 52 | MP0001853_heart_inflammation | 1.43269120 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.41005405 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.41005405 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.40480952 |
| 56 | MP0003195_calcinosis | 1.40422060 |
| 57 | MP0009278_abnormal_bone_marrow | 1.39304150 |
| 58 | MP0000858_altered_metastatic_potential | 1.39145055 |
| 59 | MP0004947_skin_inflammation | 1.39107294 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.39021947 |
| 61 | MP0002429_abnormal_blood_cell | 1.37806352 |
| 62 | MP0002722_abnormal_immune_system | 1.37075249 |
| 63 | MP0000490_abnormal_crypts_of | 1.36687768 |
| 64 | MP0004510_myositis | 1.30339507 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.28906441 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.27334951 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.26310872 |
| 68 | MP0005310_abnormal_salivary_gland | 1.26195582 |
| 69 | MP0001764_abnormal_homeostasis | 1.22921161 |
| 70 | MP0000604_amyloidosis | 1.22513138 |
| 71 | MP0009764_decreased_sensitivity_to | 1.18432969 |
| 72 | MP0002933_joint_inflammation | 1.15598771 |
| 73 | MP0003075_altered_response_to | 1.15218930 |
| 74 | MP0002006_tumorigenesis | 1.13242500 |
| 75 | MP0000371_diluted_coat_color | 1.12715465 |
| 76 | * MP0004808_abnormal_hematopoietic_stem | 1.12195409 |
| 77 | MP0001873_stomach_inflammation | 1.09523439 |
| 78 | MP0001958_emphysema | 1.06316082 |
| 79 | MP0008260_abnormal_autophagy | 1.03410990 |
| 80 | MP0003690_abnormal_glial_cell | 1.03121685 |
| 81 | * MP0005319_abnormal_enzyme/_coenzyme | 1.03008438 |
| 82 | MP0005083_abnormal_biliary_tract | 1.02019861 |
| 83 | MP0001851_eye_inflammation | 1.00592612 |
| 84 | MP0003828_pulmonary_edema | 0.98979311 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.97361694 |
| 86 | * MP0005390_skeleton_phenotype | 0.96764126 |
| 87 | MP0006054_spinal_hemorrhage | 0.95244362 |
| 88 | MP0003186_abnormal_redox_activity | 0.94207779 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 0.92303204 |
| 90 | MP0002132_abnormal_respiratory_system | 0.91999487 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91675736 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.90569752 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.89856076 |
| 94 | MP0005085_abnormal_gallbladder_physiolo | 0.89529203 |
| 95 | MP0005166_decreased_susceptibility_to | 0.89053930 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.88592828 |
| 97 | * MP0009643_abnormal_urine_homeostasis | 0.87707963 |
| 98 | MP0005023_abnormal_wound_healing | 0.87463317 |
| 99 | MP0009763_increased_sensitivity_to | 0.87099359 |
| 100 | MP0003329_amyloid_beta_deposits | 0.85584836 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.85199689 |
| 102 | MP0000681_abnormal_thyroid_gland | 0.83543947 |
| 103 | * MP0002118_abnormal_lipid_homeostasis | 0.83398131 |
| 104 | * MP0003795_abnormal_bone_structure | 0.82995709 |
| 105 | MP0000249_abnormal_blood_vessel | 0.81547185 |
| 106 | MP0003763_abnormal_thymus_physiology | 0.81368365 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.78277452 |
| 108 | MP0005165_increased_susceptibility_to | 0.78102849 |
| 109 | MP0005647_abnormal_sex_gland | 0.76588072 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.75614019 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.75310644 |
| 112 | MP0005408_hypopigmentation | 0.74541119 |
| 113 | MP0005164_abnormal_response_to | 0.72259852 |
| 114 | MP0000598_abnormal_liver_morphology | 0.71931668 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.71425755 |
| 116 | MP0005332_abnormal_amino_acid | 0.71297137 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.68688987 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.68006735 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.67279676 |
| 120 | MP0008004_abnormal_stomach_pH | 0.67035563 |
| 121 | MP0001663_abnormal_digestive_system | 0.66404842 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.66392618 |
| 123 | MP0003693_abnormal_embryo_hatching | 0.65809179 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.65210117 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.65204648 |
| 126 | MP0000609_abnormal_liver_physiology | 0.63698943 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.63530636 |
| 128 | MP0003866_abnormal_defecation | 0.62906636 |
| 129 | MP0001915_intracranial_hemorrhage | 0.59712304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 6.25517787 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.25292084 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.91184422 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.82037624 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.48815816 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.23018767 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.93696124 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.67266804 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.61248101 |
| 10 | * Dysostosis multiplex (HP:0000943) | 4.19725505 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.03287950 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.03287950 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.03287950 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61340666 |
| 15 | Obstructive lung disease (HP:0006536) | 3.61340666 |
| 16 | * Urinary glycosaminoglycan excretion (HP:0003541) | 3.56728551 |
| 17 | * Mucopolysacchariduria (HP:0008155) | 3.56728551 |
| 18 | Myositis (HP:0100614) | 3.42520719 |
| 19 | Recurrent skin infections (HP:0001581) | 3.41353412 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.33429040 |
| 21 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.33041976 |
| 22 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33041976 |
| 23 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33041976 |
| 24 | Disinhibition (HP:0000734) | 3.31573280 |
| 25 | Gingivitis (HP:0000230) | 3.24540613 |
| 26 | Increased serum ferritin (HP:0003281) | 3.19838803 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.18968460 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.18096119 |
| 29 | Glomerulonephritis (HP:0000099) | 3.13585842 |
| 30 | Cellulitis (HP:0100658) | 3.08555343 |
| 31 | Axonal loss (HP:0003447) | 3.04805065 |
| 32 | Loss of speech (HP:0002371) | 2.96994583 |
| 33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.96282701 |
| 34 | Agnosia (HP:0010524) | 2.93182537 |
| 35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.92887331 |
| 36 | Petechiae (HP:0000967) | 2.83355191 |
| 37 | Chronic otitis media (HP:0000389) | 2.80165624 |
| 38 | Prolonged neonatal jaundice (HP:0006579) | 2.78035543 |
| 39 | Recurrent viral infections (HP:0004429) | 2.76439020 |
| 40 | Abnormality of iron homeostasis (HP:0011031) | 2.76380735 |
| 41 | Periodontitis (HP:0000704) | 2.75111352 |
| 42 | Osteomyelitis (HP:0002754) | 2.73583047 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.69705582 |
| 44 | Pustule (HP:0200039) | 2.65309718 |
| 45 | Thrombocytosis (HP:0001894) | 2.64727391 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.62256363 |
| 47 | Orchitis (HP:0100796) | 2.60939181 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.55960614 |
| 49 | Cervical subluxation (HP:0003308) | 2.52863350 |
| 50 | IgM deficiency (HP:0002850) | 2.51773420 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.50675159 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.50675159 |
| 53 | Cardiomegaly (HP:0001640) | 2.50459110 |
| 54 | Amyloidosis (HP:0011034) | 2.47150978 |
| 55 | Basal ganglia calcification (HP:0002135) | 2.45843694 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.44630401 |
| 57 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.43313411 |
| 58 | Abnormality of complement system (HP:0005339) | 2.43136029 |
| 59 | Spondylolisthesis (HP:0003302) | 2.41703302 |
| 60 | Myocardial infarction (HP:0001658) | 2.41520717 |
| 61 | Urticaria (HP:0001025) | 2.39066075 |
| 62 | Meningitis (HP:0001287) | 2.38728808 |
| 63 | Pathologic fracture (HP:0002756) | 2.34682421 |
| 64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32856962 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.32036582 |
| 66 | Albinism (HP:0001022) | 2.31553773 |
| 67 | Joint hemorrhage (HP:0005261) | 2.30864343 |
| 68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29434199 |
| 69 | Epistaxis (HP:0000421) | 2.27720828 |
| 70 | Xanthomatosis (HP:0000991) | 2.24263214 |
| 71 | Vasculitis (HP:0002633) | 2.24080965 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.23031393 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.21829141 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.21829141 |
| 75 | Abnormal platelet function (HP:0011869) | 2.20836590 |
| 76 | Impaired platelet aggregation (HP:0003540) | 2.20836590 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.19531555 |
| 78 | Hypertensive crisis (HP:0100735) | 2.17454723 |
| 79 | * J-shaped sella turcica (HP:0002680) | 2.14258027 |
| 80 | Gingival bleeding (HP:0000225) | 2.13285137 |
| 81 | Nuclear cataract (HP:0100018) | 2.11943174 |
| 82 | Recurrent pneumonia (HP:0006532) | 2.10797297 |
| 83 | Hematochezia (HP:0002573) | 2.10677851 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.10314296 |
| 85 | Nephritis (HP:0000123) | 2.08347625 |
| 86 | Agammaglobulinemia (HP:0004432) | 2.05378834 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.04119340 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.03817147 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.03370871 |
| 90 | Optic neuritis (HP:0100653) | 2.03370871 |
| 91 | Arterial thrombosis (HP:0004420) | 2.03203812 |
| 92 | Leukocytosis (HP:0001974) | 2.02622220 |
| 93 | Joint stiffness (HP:0001387) | 2.02589063 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.01889486 |
| 95 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.00734141 |
| 96 | Prostate neoplasm (HP:0100787) | 2.00694011 |
| 97 | Gastrointestinal inflammation (HP:0004386) | 1.97027247 |
| 98 | Complement deficiency (HP:0004431) | 1.96665680 |
| 99 | Hyperammonemia (HP:0001987) | 1.96333997 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 1.96052474 |
| 101 | Bone pain (HP:0002653) | 1.95438831 |
| 102 | Progressive neurologic deterioration (HP:0002344) | 1.94612426 |
| 103 | Stomatitis (HP:0010280) | 1.94579723 |
| 104 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94460710 |
| 105 | Poor head control (HP:0002421) | 1.90975117 |
| 106 | Esophageal neoplasm (HP:0100751) | 1.90053735 |
| 107 | Neoplasm of head and neck (HP:0012288) | 1.90053735 |
| 108 | Cholecystitis (HP:0001082) | 1.89749399 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 1.89749399 |
| 110 | Diminished motivation (HP:0000745) | 1.88619793 |
| 111 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87418413 |
| 112 | * Thoracic kyphosis (HP:0002942) | 1.87249705 |
| 113 | Cerebral palsy (HP:0100021) | 1.87211690 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 1.85986476 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85986476 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 1.84429657 |
| 117 | Conjunctival telangiectasia (HP:0000524) | 1.82544602 |
| 118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81570752 |
| 119 | Opisthotonus (HP:0002179) | 1.81348144 |
| 120 | Seborrheic dermatitis (HP:0001051) | 1.80663594 |
| 121 | Hemoptysis (HP:0002105) | 1.80199780 |
| 122 | Skin ulcer (HP:0200042) | 1.78525153 |
| 123 | Colitis (HP:0002583) | 1.77745669 |
| 124 | Encephalitis (HP:0002383) | 1.77240976 |
| 125 | Mucosal telangiectasiae (HP:0100579) | 1.77199085 |
| 126 | Menorrhagia (HP:0000132) | 1.75419002 |
| 127 | Apathy (HP:0000741) | 1.74230561 |
| 128 | Ragged-red muscle fibers (HP:0003200) | 1.73879932 |
| 129 | Increased IgM level (HP:0003496) | 1.73416786 |
| 130 | Purpura (HP:0000979) | 1.73310781 |
| 131 | Neuronal loss in central nervous system (HP:0002529) | 1.72517516 |
| 132 | Nausea (HP:0002018) | 1.71210861 |
| 133 | Mesangial abnormality (HP:0001966) | 1.69062121 |
| 134 | Retinal atrophy (HP:0001105) | 1.68497141 |
| 135 | Abnormality of lateral ventricle (HP:0030047) | 1.67431445 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.66403680 |
| 137 | * Splenomegaly (HP:0001744) | 1.65584339 |
| 138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.64616844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.33327154 |
| 2 | KIT | 3.26976844 |
| 3 | MAP4K1 | 3.17529351 |
| 4 | IRAK4 | 2.87812449 |
| 5 | ERN1 | 2.83505821 |
| 6 | TBK1 | 2.52904523 |
| 7 | TYK2 | 2.38605772 |
| 8 | TGFBR2 | 2.29165747 |
| 9 | MAP3K14 | 2.27722728 |
| 10 | BCKDK | 2.12908635 |
| 11 | PKN2 | 2.12166272 |
| 12 | BTK | 2.08751733 |
| 13 | NME2 | 2.03266351 |
| 14 | IRAK3 | 2.02073111 |
| 15 | RIPK4 | 2.00996342 |
| 16 | CSF1R | 2.00659693 |
| 17 | ZAP70 | 1.97486089 |
| 18 | PIM2 | 1.92067680 |
| 19 | TRIB3 | 1.90494443 |
| 20 | TAOK3 | 1.90432051 |
| 21 | MAP2K3 | 1.90271732 |
| 22 | TEC | 1.83335932 |
| 23 | TAOK2 | 1.78069815 |
| 24 | SCYL2 | 1.72733394 |
| 25 | SMG1 | 1.67629028 |
| 26 | MAPKAPK3 | 1.66496918 |
| 27 | PRPF4B | 1.63980845 |
| 28 | FES | 1.63082340 |
| 29 | VRK2 | 1.62164158 |
| 30 | EPHB1 | 1.56838914 |
| 31 | IKBKB | 1.55585530 |
| 32 | JAK3 | 1.51609329 |
| 33 | SYK | 1.50825797 |
| 34 | STK10 | 1.50553557 |
| 35 | NEK9 | 1.50366523 |
| 36 | CAMK1D | 1.41055543 |
| 37 | HCK | 1.36598918 |
| 38 | IKBKE | 1.35345157 |
| 39 | JAK1 | 1.32218513 |
| 40 | LYN | 1.32102013 |
| 41 | FLT3 | 1.30354332 |
| 42 | CSK | 1.24705082 |
| 43 | LRRK2 | 1.22537251 |
| 44 | RPS6KA4 | 1.21996093 |
| 45 | SIK1 | 1.18738742 |
| 46 | TAOK1 | 1.18426622 |
| 47 | TNK2 | 1.18216038 |
| 48 | PAK4 | 1.17174739 |
| 49 | TTN | 1.12864031 |
| 50 | LCK | 1.09494078 |
| 51 | TXK | 1.07616936 |
| 52 | TRPM7 | 1.07305843 |
| 53 | EEF2K | 1.01897783 |
| 54 | MAP2K6 | 1.00215430 |
| 55 | KDR | 0.99706221 |
| 56 | ITK | 0.99600710 |
| 57 | JAK2 | 0.97501795 |
| 58 | CAMKK2 | 0.97355098 |
| 59 | MATK | 0.96797921 |
| 60 | EPHA2 | 0.96636234 |
| 61 | MAPK11 | 0.95251579 |
| 62 | MAP2K2 | 0.94325888 |
| 63 | PTK6 | 0.90348800 |
| 64 | PIM1 | 0.90159711 |
| 65 | CLK1 | 0.88369797 |
| 66 | RPS6KB2 | 0.88254037 |
| 67 | ARAF | 0.86925231 |
| 68 | TESK2 | 0.83257105 |
| 69 | MAP3K3 | 0.82944258 |
| 70 | ABL2 | 0.80662015 |
| 71 | DAPK1 | 0.77007906 |
| 72 | EIF2AK3 | 0.76491729 |
| 73 | CDK6 | 0.75333036 |
| 74 | STK4 | 0.75324377 |
| 75 | MST1R | 0.74164669 |
| 76 | BMPR2 | 0.73963716 |
| 77 | SIK3 | 0.70098811 |
| 78 | GRK6 | 0.69839391 |
| 79 | EPHA3 | 0.69036201 |
| 80 | MAP3K11 | 0.67870611 |
| 81 | CHUK | 0.67783159 |
| 82 | PIK3CG | 0.66786122 |
| 83 | BMX | 0.66288306 |
| 84 | HIPK2 | 0.63349954 |
| 85 | TGFBR1 | 0.63266768 |
| 86 | ABL1 | 0.62856147 |
| 87 | CDC42BPA | 0.60005410 |
| 88 | NEK2 | 0.58418482 |
| 89 | CAMK1G | 0.57995854 |
| 90 | PDK2 | 0.57769311 |
| 91 | PDPK1 | 0.56896708 |
| 92 | MAPKAPK2 | 0.56767434 |
| 93 | PRKCD | 0.56581323 |
| 94 | ADRBK2 | 0.55875667 |
| 95 | MAP3K8 | 0.55563956 |
| 96 | RPS6KA6 | 0.55463497 |
| 97 | ICK | 0.55305372 |
| 98 | EGFR | 0.54459334 |
| 99 | TESK1 | 0.54407978 |
| 100 | IRAK1 | 0.54038376 |
| 101 | CDK7 | 0.53948808 |
| 102 | PBK | 0.53472644 |
| 103 | FGFR4 | 0.51029469 |
| 104 | IRAK2 | 0.50975535 |
| 105 | FGR | 0.50747417 |
| 106 | MAP3K13 | 0.50712994 |
| 107 | MAP3K10 | 0.49978360 |
| 108 | MARK3 | 0.48890653 |
| 109 | RIPK1 | 0.48341964 |
| 110 | RPS6KC1 | 0.47126417 |
| 111 | RPS6KL1 | 0.47126417 |
| 112 | CAMKK1 | 0.47122538 |
| 113 | EIF2AK2 | 0.45862090 |
| 114 | RPS6KA2 | 0.45538857 |
| 115 | STK3 | 0.45503903 |
| 116 | CDK12 | 0.45261210 |
| 117 | PRKG2 | 0.41941144 |
| 118 | LIMK1 | 0.41144683 |
| 119 | YES1 | 0.38830629 |
| 120 | CDK4 | 0.38439822 |
| 121 | PDK1 | 0.38302733 |
| 122 | MOS | 0.36376669 |
| 123 | SIK2 | 0.35726289 |
| 124 | MAPK3 | 0.35389245 |
| 125 | MAPK4 | 0.34466306 |
| 126 | BRSK2 | 0.33955054 |
| 127 | GRK7 | 0.31366945 |
| 128 | PASK | 0.31358370 |
| 129 | MAP3K1 | 0.31121086 |
| 130 | IGF1R | 0.30979923 |
| 131 | PAK1 | 0.30075596 |
| 132 | FGFR3 | 0.28397246 |
| 133 | MAP3K5 | 0.27894812 |
| 134 | ATR | 0.27716096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.57641518 |
| 2 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.42590992 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 3.24679900 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.20004546 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.10529638 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35356192 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.21649024 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.14418746 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.09123752 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06220235 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.01204179 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.91118852 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.87201434 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85398224 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84406510 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82830967 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.67548603 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56238695 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55879617 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55713227 |
| 21 | Apoptosis_Homo sapiens_hsa04210 | 1.52759316 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51865710 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.47824831 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46264008 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44899163 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.43224942 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42412663 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38285725 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35963398 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35050813 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34568394 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33840402 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33835994 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.33253967 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.32193430 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31482396 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31236192 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30998421 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29743160 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28689947 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27175750 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.25055399 |
| 43 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19735500 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19246308 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19022899 |
| 46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18143979 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14052193 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11041324 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.09209301 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08037278 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07776062 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07671165 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05672388 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01756556 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99659387 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.97008505 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96934742 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.95732524 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95189898 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92683288 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90635467 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.88125603 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87931890 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87897709 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87379078 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87256484 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87224675 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.86969932 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85351533 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.84320760 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83639536 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82064341 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.80211090 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79379315 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79229706 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78619747 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78287296 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76263328 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75744563 |
| 80 | Base excision repair_Homo sapiens_hsa03410 | 0.74239216 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73352323 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73299072 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73062841 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.72766547 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72361354 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71438716 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70933940 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.70276023 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.70192976 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69925838 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.69708350 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.69437619 |
| 93 | Mismatch repair_Homo sapiens_hsa03430 | 0.67009632 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.66004941 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65974418 |
| 96 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65132532 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63052897 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62972801 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62116658 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61882012 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61463205 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61301787 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61273579 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59065044 |
| 105 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58152174 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57672894 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57401047 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56407490 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56359875 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55332177 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53811001 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53618443 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52306395 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52164048 |
| 115 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51738698 |
| 116 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51123010 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48741236 |
| 118 | Homologous recombination_Homo sapiens_hsa03440 | 0.48133556 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45857304 |
| 120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45026718 |
| 121 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42773001 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42703207 |
| 123 | Protein export_Homo sapiens_hsa03060 | 0.41198607 |
| 124 | Ribosome_Homo sapiens_hsa03010 | 0.41000396 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40359498 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38250925 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38120530 |
| 128 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37973480 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34929701 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.34929412 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34232680 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31785009 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31757637 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30951887 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28270530 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.27395946 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26462112 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25665493 |
| 139 | Proteasome_Homo sapiens_hsa03050 | 0.25578499 |

